Ayurveda management of bronchial asthma in children

Randomized controlled clinical trial to evaluate the effect of Shati Arka nebulization in acute episodes of Tamakashwasa(Bronchial asthma) in children.

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/08/044803

Enrollment

120

Registered

2022-08-22

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J22- Unspecified acute lower respiratory infection

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children of age group 8-12 years, fulfilling the diagnostic criteria, irrespective of gender, religion and socio-economic status. 2.Children with mild to moderate exacerbation of asthma. 3.Children with Covid-19 negative test report(arbitrary). 4.Those parents who are willing to participate their child in the study and ready to sign the assent form.

Exclusion criteria

Exclusion criteria: 1.Severe and complicated bronchial asthma those need intense care. 2.Patients on regular Corticosteroids 3.Diagnosed C/O tuberculosis, plueral effusion, emphysema, lung abscess, bronchiectasis, pleurisy, nasal polyps. 4.Congenital lung or cardiac anomalies. 5.Chronic debilitating diseases 6.Children with severe form of asthma with any one of SPO2

Design outcomes

Primary

Measure	Time frame
To relieve the obstruction and to increase the functional ability of the lung during the mild to moderate acute episodes of bronchial asthma in children age 8-12 years by spirometric measurement and PEFM using Shati Arka nebulization.Timepoint: The patients will be monitored daily during treatment nebulization before and after each nebulization for 3 days and once after 7days of treatment for relapse of acute exacerbation	—

Measure

Time frame

To relieve the obstruction and to increase the functional ability of the lung during the mild to moderate acute episodes of bronchial asthma in children age 8-12 years by spirometric measurement and PEFM using Shati Arka nebulization.Timepoint: The patients will be monitored daily during treatment nebulization before and after each nebulization for 3 days and once after 7days of treatment for relapse of acute exacerbation

—

Secondary

Measure	Time frame
To assess the changes in objective parameters like Peak Flow Meter and spirometry measurementsTimepoint: PEF 8th hourly before and after each nebulization Spirometry before and after the course of treatment that 3 days;To reduce relapse of acute exacerbationTimepoint: after 1 week	—

Countries

India

Contacts

Public ContactDrShwethaD

SDM Collgege of Ayurveda and Hospital

abtittu@gmail.com9480624829

Outcome results